Cargando…
Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer International Publishing
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620249/ https://www.ncbi.nlm.nih.gov/pubmed/31115842 http://dx.doi.org/10.1007/s11136-019-02204-x |
| _version_ | 1783434007771348992 |
|---|---|
| author | Andersen, Henning Mantegazza, Renato Wang, Jing Jing O’Brien, Fanny Patra, Kaushik Howard, James F. |
| author_facet | Andersen, Henning Mantegazza, Renato Wang, Jing Jing O’Brien, Fanny Patra, Kaushik Howard, James F. |
| author_sort | Andersen, Henning |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6620249 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2019 |
| publisher | Springer International Publishing |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-66202492019-07-28 Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis Andersen, Henning Mantegazza, Renato Wang, Jing Jing O’Brien, Fanny Patra, Kaushik Howard, James F. Qual Life Res Correction Springer International Publishing 2019-05-21 2019 /pmc/articles/PMC6620249/ /pubmed/31115842 http://dx.doi.org/10.1007/s11136-019-02204-x Text en © The Author(s) 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Correction Andersen, Henning Mantegazza, Renato Wang, Jing Jing O’Brien, Fanny Patra, Kaushik Howard, James F. Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis |
| title | Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis |
| title_full | Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis |
| title_fullStr | Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis |
| title_full_unstemmed | Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis |
| title_short | Correction to: Eculizumab improves fatigue in refractory generalized myasthenia gravis |
| title_sort | correction to: eculizumab improves fatigue in refractory generalized myasthenia gravis |
| topic | Correction |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6620249/ https://www.ncbi.nlm.nih.gov/pubmed/31115842 http://dx.doi.org/10.1007/s11136-019-02204-x |
| work_keys_str_mv | AT andersenhenning correctiontoeculizumabimprovesfatigueinrefractorygeneralizedmyastheniagravis AT mantegazzarenato correctiontoeculizumabimprovesfatigueinrefractorygeneralizedmyastheniagravis AT wangjingjing correctiontoeculizumabimprovesfatigueinrefractorygeneralizedmyastheniagravis AT obrienfanny correctiontoeculizumabimprovesfatigueinrefractorygeneralizedmyastheniagravis AT patrakaushik correctiontoeculizumabimprovesfatigueinrefractorygeneralizedmyastheniagravis AT howardjamesf correctiontoeculizumabimprovesfatigueinrefractorygeneralizedmyastheniagravis AT correctiontoeculizumabimprovesfatigueinrefractorygeneralizedmyastheniagravis |